Via a random Google search, this profile in the ABA Journal of Dr. Andrew Chadeayne, a lawyer and PhD chemist:
From a desk in the back of his garage in Issaquah, Washington, a suburb of Seattle, Andrew Chadeayne is quietly, steadily spearheading the convergence of science, law and psychedelic drugs.
Chadeayne, who holds a doctorate in chemistry, is also a patent lawyer. His experience includes intellectual property work for pharmaceutical companies and a major freight forwarder. But it was his work for the revolutionary cannabis research company Ebbu that ignited his interest in developing and commercializing the mind-altering properties of much-maligned plants.
In 2018, Ebbu sold in a deal valued north of $330 million, and Chadeayne decided not to stay with the company. Instead, he founded a company called CaaMTech to explore another pharmacological edible: the magic mushroom.
Pretty interesting stuff - read the whole thing.